Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 886 AL 900

Quantifying motivational deficits and apathy: a review of the literature

Weiser M, Garibaldi G.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1060-81. doi: 10.1016/j.euroneuro.2014.08.018. Epub 2015 Mar 5.

Could α-synuclein amyloid-like aggregates trigger a prionic neuronal invasion?

Busquets MA, Espargaró A, Estelrich J, Sabate R.

Biomed Res Int. 2015;2015:172018. doi: 10.1155/2015/172018. Epub 2015 Mar 19.

Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease

Howell MJ, Schenck CH.

JAMA Neurol. 2015 Jun;72(6):707-12. doi: 10.1001/jamaneurol.2014.4563.

[Delayed emergence from general anesthesia in a dementia patient with Lewy bodies]

Takebe S, Inoue K, Kawanishi H, Nakamura H, Ohnishi A, Ohnishi J, Yatsu Y, Nagai A, Matsuda R, Hirasaki A.

Masui. 2015 Jan;64(1):81-3.

Glutathione S-transferase T1 and M1 null genotypes and Parkinson's disease risk: evidence from an updated meta-analysis

Liu H, Peng J, Gao J, Zheng F, Tie C.

Neurol Sci. 2015 Sep;36(9):1559-65. doi: 10.1007/s10072-015-2159-4. Epub 2015 Apr 14.

Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis

Sako W, Murakami N, Izumi Y, Kaji R.

J Neurol Sci. 2015 May 15;352(1-2):84-7. doi: 10.1016/j.jns.2015.03.041. Epub 2015 Apr 7.

Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors

Sierra M, Carnicella S, Strafella AP, Bichon A, Lhommée E, Castrioto A, Chabardes S, Thobois S, Krack P.

J Parkinsons Dis. 2015;5(3):625-36. doi: 10.3233/JPD-150535.

Role of Toll-like receptor/MYD88 signaling in neurodegenerative diseases

Xiang W, Chao ZY, Feng DY.

Rev Neurosci. 2015;26(4):407-14. doi: 10.1515/revneuro-2014-0067.

The effectiveness of Tai Chi for patients with Parkinson's disease: study protocol for a randomized controlled trial

Yang Y, Hao YL, Tian WJ, Gong L, Zhang K, Shi QG, Sun DF, Li CL, Zhao ZL.

Trials. 2015 Mar 24;16:111. doi: 10.1186/s13063-015-0639-8.

Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease

Sandoval-Rincón M, Sáenz-Farret M, Miguel-Puga A, Micheli F, Arias-Carrión O.

Front Neurol. 2015 Mar 31;6:71. doi: 10.3389/fneur.2015.00071. eCollection 2015.

The Interplay between Alpha-Synuclein Clearance and Spreading

Lopes da Fonseca T, Villar-Piqué A, Outeiro TF.

Biomolecules. 2015 Apr 14;5(2):435-71. doi: 10.3390/biom5020435.

Effects of dual-task training on balance and executive functions in Parkinson's disease: A pilot study

Fernandes Â, Rocha N, Santos R, Tavares JM.

Somatosens Mot Res. 2015;32(2):122-7. doi: 10.3109/08990220.2014.1002605. Epub 2015 Apr 15.

Parkinsonism related to varenicline in a patient during smoking cessation

Uca AU, Kozak HH, Uğuz F, Gümüş H.

J Clin Psychopharmacol. 2015 Jun;35(3):355-7. doi: 10.1097/JCP.0000000000000328.

Neuroprotective effects of the cultivated Chondrus crispus in a C. elegans model of Parkinson's disease

Liu J, Banskota AH, Critchley AT, Hafting J, Prithiviraj B.

Mar Drugs. 2015 Apr 14;13(4):2250-66. doi: 10.3390/md13042250.

Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety

Othman AA, Chatamra K, Mohamed ME, Dutta S, Benesh J, Yanagawa M, Nagai M.

Clin Pharmacokinet. 2015 Sep;54(9):975-84. doi: 10.1007/s40262-015-0265-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias